• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read.

作者信息

Jauhar Sameer, Hayes Joseph

机构信息

Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, SE5 8 AF, UK.

Division of Psychiatry, University College London, UK.

出版信息

Addict Behav. 2019 Oct;97:122-125. doi: 10.1016/j.addbeh.2019.01.025. Epub 2019 Jan 23.

DOI:10.1016/j.addbeh.2019.01.025
PMID:30732861
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7613096/
Abstract
摘要

相似文献

1
The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read.抗抑郁药之战：从戴维斯和里德对抗抑郁药撤药效应的系统评价中我们能得出什么结论，又不能得出什么结论。
Addict Behav. 2019 Oct;97:122-125. doi: 10.1016/j.addbeh.2019.01.025. Epub 2019 Jan 23.
2
Corrigendum to "The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read" [Addictive Behaviors (2019)].《抗抑郁药之战：从戴维斯和里德对抗抑郁药戒断效应的系统评价中我们能得出及不能得出的结论》勘误 [《成瘾行为》（2019年）]
Addict Behav. 2019 Oct;97:126. doi: 10.1016/j.addbeh.2019.05.015. Epub 2019 May 31.
3
Antidepressants: can't live with them, can't live without them.
CNS Spectr. 2010 Mar;15(3):146-7. doi: 10.1017/s1092852900027395.
4
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理：一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
5
A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?一项关于抗抑郁药戒断效应的发生率、严重程度和持续时间的系统评价：指南是否基于证据？
Addict Behav. 2019 Oct;97:111-121. doi: 10.1016/j.addbeh.2018.08.027. Epub 2018 Sep 4.
6
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.成人抑郁和焦虑障碍中长效抗抑郁药停药与继续使用的方法。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2.
7
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.评估从已发表数据综述中得出的抗抑郁药撤药风险。
CNS Drugs. 2023 Feb;37(2):143-157. doi: 10.1007/s40263-022-00960-y. Epub 2022 Dec 14.
8
Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review.抗抑郁药戒断症状的发生率及危险因素：一项荟萃分析与系统评价
Mol Psychiatry. 2025 May;30(5):1758-1769. doi: 10.1038/s41380-024-02782-4. Epub 2024 Oct 11.
9
Antidepressants for depressed elderly.用于老年抑郁症患者的抗抑郁药
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD003491. doi: 10.1002/14651858.CD003491.pub2.
10
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis.抗抑郁药停药症状的发生率：系统评价和荟萃分析。
Lancet Psychiatry. 2024 Jul;11(7):526-535. doi: 10.1016/S2215-0366(24)00133-0. Epub 2024 Jun 5.

引用本文的文献

1
Evidence on antidepressant withdrawal: an appraisal and reanalysis of a recent systematic review.抗抑郁药撤药的证据：对近期一项系统评价的评估与重新分析
Psychol Med. 2025 Jul 22;55:e191. doi: 10.1017/S0033291725100652.
2
Trazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability.曲唑酮每日一次给药：应对抗抑郁药安全性和耐受性挑战的一种方案。
Neurosci Appl. 2023 May 22;2:101127. doi: 10.1016/j.nsa.2023.101127. eCollection 2023.
3
Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors.

本文引用的文献

1
A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?一项关于抗抑郁药戒断效应的发生率、严重程度和持续时间的系统评价：指南是否基于证据？
Addict Behav. 2019 Oct;97:111-121. doi: 10.1016/j.addbeh.2018.08.027. Epub 2018 Sep 4.
2
Characteristics of Escitalopram Discontinuation Syndrome: A Preliminary Study.艾司西酞普兰停药综合征的特征：一项初步研究。
Clin Neuropharmacol. 2016 May-Jun;39(3):125-7. doi: 10.1097/WNF.0000000000000139.
3
Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.
急性氨甲酰化促红细胞生成素可减轻社会应激诱导的焦虑和抑郁相关行为。
Neuropharmacology. 2025 Jun 11;278:110558. doi: 10.1016/j.neuropharm.2025.110558.
4
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.精神类药物停药：各类药物证据综合。
Mol Psychiatry. 2024 Aug;29(8):2575-2586. doi: 10.1038/s41380-024-02445-4. Epub 2024 Mar 19.
5
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.评估从已发表数据综述中得出的抗抑郁药撤药风险。
CNS Drugs. 2023 Feb;37(2):143-157. doi: 10.1007/s40263-022-00960-y. Epub 2022 Dec 14.
6
Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials.经前期综合征采用间歇性选择性 5-羟色胺再摄取抑制剂治疗的系统评价和随机试验荟萃分析。
J Psychopharmacol. 2023 Mar;37(3):261-267. doi: 10.1177/02698811221099645. Epub 2022 Jun 10.
7
The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.“患者的声音”：经历抗抑郁药物戒断症状的患者常常被忽视，或被误诊为病情复发，或患有新的疾病。
Ther Adv Psychopharmacol. 2020 Nov 9;10:2045125320967183. doi: 10.1177/2045125320967183. eCollection 2020.
8
Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.抑郁和焦虑障碍患者停用抗抑郁药的障碍：文献综述与临床建议
Ther Adv Psychopharmacol. 2020 Jun 10;10:2045125320933404. doi: 10.1177/2045125320933404. eCollection 2020.
9
Antidepressant withdrawal - the tide is finally turning.抗抑郁药戒断——潮流终于转向。
Epidemiol Psychiatr Sci. 2019 Aug 22;29:e52. doi: 10.1017/S2045796019000465.
10
Antidepressants, withdrawal, and addiction; where are we now?抗抑郁药、戒断和成瘾；我们现在在哪里？
J Psychopharmacol. 2019 Jun;33(6):655-659. doi: 10.1177/0269881119845799. Epub 2019 May 21.
选择性 5-羟色胺再摄取抑制剂抗抑郁药停药综合征：临床证据及可能涉及的机制综述。
Front Pharmacol. 2013 Apr 16;4:45. doi: 10.3389/fphar.2013.00045. eCollection 2013.
4
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析的首选报告项目：PRISMA声明。
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64. doi: 10.7326/0003-4819-151-4-200908180-00135. Epub 2009 Jul 20.
5
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.抗抑郁药逐渐减药速度对停药症状发生率的影响：一项随机研究。
J Psychopharmacol. 2008 May;22(3):330-2. doi: 10.1177/0269881107081550.
6
Discontinuation symptoms in depression and anxiety disorders.抑郁和焦虑症中的停药症状。
Int J Neuropsychopharmacol. 2007 Feb;10(1):73-84. doi: 10.1017/S1461145705006358. Epub 2005 Dec 19.
7
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.舍曲林与文拉法辛缓释剂治疗重度抑郁症的随机试验：疗效与停药症状
J Clin Psychiatry. 2005 Oct;66(10):1312-20. doi: 10.4088/jcp.v66n1015.
8
A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.一项关于艾司西酞普兰预防广泛性社交焦虑障碍的为期24周的随机、双盲、安慰剂对照研究。
J Clin Psychiatry. 2005 Oct;66(10):1270-8. doi: 10.4088/jcp.v66n1009.
9
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.阿戈美拉汀无撤药症状及帕罗西汀有撤药症状：一项随机、双盲、安慰剂对照的撤药研究。
Int Clin Psychopharmacol. 2004 Sep;19(5):271-80. doi: 10.1097/01.yic.0000137184.64610.c8.
10
Tofranil-treatment of endogenous depressions.丙咪嗪治疗内源性抑郁症。
Acta Psychiatr Scand. 1959;34(4):387-97. doi: 10.1111/j.1600-0447.1959.tb07529.x.